Targeted Ultrasound With Contrast Enhancement for Reassessment of MRI‐Detected BI‐RADS 4 Nonmass Enhancement: Impact on Biopsy Reduction and DCIS Detection
The Breast Journal · 2026-01 · 2026 (1)
DOI: 10.1155/tbj/1932231 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Breast Journal, online erschienen am 05.11.2026. Verfasst von Qinghua Niu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, shsmu.edu.cn. Hauptthemen laut MEDLINE: Breast Neoplasms, Magnetic Resonance Imaging, Carcinoma, Intraductal, Noninfiltrating, Ultrasonography, Mammary. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai Municipal Education Commission.
Abstract (Originalsprache)
Objective
To evaluate whether targeted ultrasound (TUS) combined with contrast‐enhanced ultrasound (CEUS) can safely reclassify MRI‐detected BI‐RADS 4 nonmass enhancement (NME) lesions to reduce unnecessary biopsies while maintaining high diagnostic sensitivity for breast cancer. Materials and Methods In this prospective study (2017–2023), we enrolled 169 MRI‐detected BI‐RADS 4 NME lesions in 167 women (23–84 years). All patients underwent TUS and CEUS within one week after MRI, followed by surgical pathology. We evaluated whether TUS combined with CEUS could reclassify lesions to avoid biopsy without compromising cancer detection.
Results
Among 169 lesions (83 benign, 86 malignant), TUS detected 97.0%. Using predefined CEUS benign criteria, 36/83 benign lesions (43.4%) and 39/169 overall (23.1%) could have safely avoided biopsy. Diagnostic sensitivity remained high (96.5%, 83/86). CEUS significantly improved detection of DCIS, upgrading 87.5% (21/24) of MRI‐BI‐RADS 4a DCIS/DCIS with microinvasion to BI‐RADS ≥4b. False‐negative cases were limited to three lesions in challenging anatomical locations (subareolar or occult). Biopsy reduction was highest in asymptomatic patients, lesions ≤ 2 cm, homogeneous enhancement, and MRI BI‐RADS 4a.
Conclusions
TUS combined with CEUS can substantially reduce unnecessary biopsies for MRI‐detected BI‐RADS 4 NME while maintaining excellent sensitivity. This approach is particularly effective for MRI BI‐RADS 4a lesions and small homogeneous NME and may provide a clinically practical strategy for improving diagnostic efficiency in breast cancer care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ultrasound, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, shsmu.edu.cn.
- Department of Ultrasound, Qingdao Hospital, University of Health and Rehabilitation Sciences (Qingdao Municipal Hospital), Qingdao, China.
- Department of Ultrasound, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, shsmu.edu.cn.
- Department of Ultrasound, Shanghai YangZhi Rehabilitation Hospital (Shanghai Sunshine Rehabilitation Center), Tongji University School of Medicine, Shanghai, China, tongji.edu.cn.
- Department of Ultrasound, Huashan Hospital, Fudan University, Shanghai, China, fudan.edu.cn.
- Department of Radiology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China, shsmu.edu.cn.
ORCID-Profile: Qinghua Niu, Ting Sun, Mingxuan Li, Lianfang Du, Yingyu Cai, Lifang Jin, Chao Jia, Hui Li, An Chen, Fan Li
Förderung
- Shanghai Chest Hospital
- Shanghai Jiao Tong University
- Shanghai Municipal Education Commission
- Songjiang District Science and Technology Research Project
Zitieren
APA
Niu, Q., Sun, T., Li, M., Du, L., Cai, Y., Jin, L., Jia, C., Li, H., Chen, A., & Li, F. (2026). Targeted Ultrasound With Contrast Enhancement for Reassessment of MRI‐Detected BI‐RADS 4 Nonmass Enhancement: Impact on Biopsy Reduction and DCIS Detection. The Breast Journal, 2026(1). https://doi.org/10.1155/tbj/1932231
Vancouver
Niu Q, Sun T, Li M, Du L, Cai Y, Jin L, et al. Targeted Ultrasound With Contrast Enhancement for Reassessment of MRI‐Detected BI‐RADS 4 Nonmass Enhancement: Impact on Biopsy Reduction and DCIS Detection. The Breast Journal. 2026;2026(1). doi:10.1155/tbj/1932231
BibTeX
@article{Niu2026,
author = {Niu, Qinghua and Sun, Ting and Li, Mingxuan and Du, Lianfang and Cai, Yingyu and Jin, Lifang and Jia, Chao and Li, Hui and Chen, An and Li, Fan},
title = {Targeted Ultrasound With Contrast Enhancement for Reassessment of MRI‐Detected BI‐RADS 4 Nonmass Enhancement: Impact on Biopsy Reduction and DCIS Detection},
journal = {The Breast Journal},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/tbj/1932231}
}
EUVIMED